February, 2018.

Slides:



Advertisements
Similar presentations
Global Forum on Bioethics in Research – nearing 10 years of dialogue
Advertisements

Research Leaders: Meeting the challenge Mark Walport 19 November 2008.
David M. Pollock Medical College of Georgia Discovery-Academia.
.. Collaborations and Global Alliances for Health Mirta Roses Periago Director Collaborations and Global Alliances for Health Mirta Roses Periago Director.
Pharmaceuticals and Global Health Inequalities and Innovation in the 21 st Century.
TBD-UK: The UK response in the discovery and development of new TB drugs. Dr Geoff Coxon Deputy Leader & Director of Medicinal Chemistry, TBD-UK APPG-TB.
7 th Framework Programme (FP7) - Malta’s participation th January 2013 Anthea Fabri FP7 National Coordinator Malta Council for Science and.
NMP-NCP meeting - Brussels, 27 Jan 2005 Towards FP 7: Preliminary principles and orientations… Nicholas Hartley European Commission DG Research DG Research.
South Africa’s S&T partnership with the European Union From FP4 to Horizon 2020 Daan du Toit Senior S&T Representative to the EU.
Research & Innovation Evolution from IMI1 to IMI2: challenges ahead Elmar Nimmesgern, PhD DG Research & Innovation 1.
Positioning for Growth - an Action Agenda for the Australian Spatial Information Industry Peter Holland General Manager AUSLIG Australia’s national mapping.
Research Infrastructures The Research Infrastructures in FP7.
1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.
HEALTH INFORMATION LITERACY HIV AIDS : TOPIC 4 Project Director: N. C. Broering Project Manager: G. A. Chauncey Sponsored by Pacific College of Oriental.
Institute of Life Science Phase 2 Project Overview School Staff Assembly 10 th June 2009.
Biodiversity Finance Program Secretariat of Convention on Biological Diversity Yibin XIANG
GEO Work Plan Symposium 2012 ID-05 Resource Mobilization for Capacity Building (individual, institutional & infrastructure)
1 Case Study Innovative Medicines Initiative (IMI) Karen Strandgaard EFPIA EuroConference, Brussels April 26th, 2006.
WHO Expert Working Group on R&D Financing Stop TB New Tools Working Groups Marcos Espinal Executive Secretary.
September 13, 2007SGH&M2B International&Training Workshop What does the European Technology Platform “Innovative Medicines initiative” offer? Vitalijs.
ResearchEuropean Commission FP 6 - Thematic Priority 1 International co-operation.
Climate Change Uncertainties: Opportunities for Business Innovation? The Business Perspective: UPMC Allison Robinson, PhD, MS Director, Environmental Initiatives.
Policy Research and Innovation Research and Innovation Enhancing and focusing EU international cooperation in research and innovation: A strategic approach.
Vaccinomics: social and science systems in transition Farah Huzair Innogen, The Open University.
ST-09-01: Catalyzing Research and Development (R&D) Funding for GEOSS Florence Béroud, EC Jérome Bequignon, ESA Kathy Fontaine, US ST Kick-off Meeting.
Science and Engineering Diaspora: Potential Role in STEM Training and Education Franklin A. Carrero-Martínez, Ph.D. Science Policy Officer Office of the.
International Bureau of the BMBF - Creating international research and education networks 1 Creating international research and education networks Petra.
Kiel University, Germany Institute for Natural Resource Conservation Department of Ecosystem Management Benjamin Burkhard (Project coordinator) Enhancing.
E u r o p e a n C o m m i s s i o nCommunity Research Global Change and Ecosystems EU environmental research : Part B Policy objectives  Lisbon strategy.
National Body-Worn Camera Toolkit Kristen Mahoney Deputy Director Bureau of Justice Assistance © ©2015.
HORIZON 2020 SC1-Health, demographic change and wellbeing challenge Марина Николовска Министерство за образование и наука
Royal Society of Chemistry Food Group Vision & Mission June 2015.
1 PRIORITY MEDICINES FOR EUROPE AND THE WORLD Barriers to Pharmaceutical Innovation Richard Laing EDM/PAR WHO.
The 7th Framework Programme for Research: Strategy of international cooperation activities Robert Burmanjer Head of Unit, “International Scientific Cooperation.
Laura Marin Project Manager of JPIAMR Central Secretariat Swedish Research Council April 2016 From national plans to joint calls and capacity.
Science & Technology for National Progress in African Region: Highlights of Regional Strategy and Action Professor Gabriel B. Ogunmola, FAS President,
EU Horizon 2020 Coordination and support action Enhancing ecoSysteM sERvices mApping for poLicy and Decision mAking Project coordinator: Benjamin Burkhard,
European Funding Opportunities in Health University of the West of England 26 March 2010 Emma Carey
The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.
Success Stories of Globalization in Korean Pharma
A Survey of the Swedish Biotech pipeline
— Creative india, innovative indiA
Lessons Learned Through HBD: The Regulator’s View - US FDA
The role of the National Contact Points
Participation of Patient Advocates in Community Advisory Boards A case-study: the HIV European Community Advisory Board (ECAB)
Update on mapping of national AMR research landscape
Global AMR R&D Hub Brussels, 26. February 2018.
Stairway to Excellence JRC.B3 Territorial Development
The STOP TB Working Group on Diagnostics
Including AMR Scientists in LMICs in JPIAMR Calls for multidisciplinary studies, including One Health approaches Maria Teresa Bejarano. MD, PhD Senior.
Call topic identification for 2019 call
The Commission Strategy on TB vaccine research
STRUCTURED DIALOGUE FOLLOW UP
Economic models to stimulate antibiotic development
JPIAMR ACTIVITY UPDATE
Innovative Medicines Initiative:
ICTMS Communicating Trial Results to participants
JPIAMR 2018 activity update
Evaluation Activities
Overview AMR international initiatives – The Landscape
Commission strategy to
SC1 Health, demographic change and well-being
Royal Society of Chemistry Food Group
SRIA Roadmap Jonathan Pearce
JPIAMR – Activity Update
Chamber Colloquium 13 February 2014 THE WAY FORWARD
Industry WG Update Jonathan Pearce
Laura Marin JPIAMR Head of Secretariat Swedish Research Council
Experience of the implementation of FP6; preparations towards FP7
- Kick-off meeting - ERANET Cofund BlueBio WP4 (Leader: AEI)
Presentation transcript:

February, 2018

ANTIBIOTIC DRUG DEVELOPMENT INITIATIVES Phase I Phase II Phase III Basic Science Pre-clinical JPIAMR National Science Research Agencies EC FP / ERC IMI / ND4BB BARDA NIH / NIAID Wellcome Trust CARB-X GARDR-P EIB’s InnovFin UK / China Global Innovation Fund Existed Prior 2016 Recently Launched

Innovation and Working in Collaboration Strategic Research Agenda - refresh with strengthened innovation links to industry and policy Guidelines - on how academia and industry can collaborate within JPIAMR Mapping Existing National Support Mechanisms - to support consideration of models for international support AMR Projects Database - to support industry collaboration Dialog - Creating and maintaining dialogue with industry and relevant stakeholders. Examples include Participation in IMI Infections SGG Supporting transnational discussions on clinical trials

THANK YOU! www.jpiamr.eu @JPIonAMR secretariat.jpiamr@vr.se Acknowledgments: VRI Working Group

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.